University of Michigan: Renal Insufficiency, Chronic trials
The registry lists 14 Renal Insufficiency, Chronic studies with University of Michigan as lead sponsor. 2 are open to participants now and 4 have results posted.
Phase 2 2Phase 4 1No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal CenterEnrolling by invitationNCT01016613
- University of Michigan "Nephrology Research BioBank"RecruitingNCT00381121
- Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease PatientsTerminatedNCT03539861Not applicableResults posted
- Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5CompletedNCT02392208Phase 4Results posted
- Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and AlbuminuriaCompletedNCT00625820Phase 2Results posted
- Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric OxideTerminatedNCT00356265Not applicableResults posted
- Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD)Active, not recruitingNCT06189807Not applicable
- Controlling Hypertension Through Education and Coaching in Kidney DiseaseCompletedNCT04087798Not applicable
- Multi-disciplinary Participatory Design of a Process to Deliver a CKD Diagnosis in Primary CareCompletedNCT03084159Not applicable
- Nebivolol Versus Sustained Release Metoprolol Succinate in Patients With Chronic Kidney DiseaseCompletedNCT01291888
- Lowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover TrialCompletedNCT00974636Not applicable
- Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC StudyCompletedNCT00396123
- ADMA Levels in End-Stage Renal DiseaseCompletedNCT00350974
- Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On DialysisCompletedNCT00242164Phase 2